Author:
Latour Yvonne L.,McNamara Kara M.,Allaman Margaret M.,Barry Daniel P.,Smith Thaddeus M.,Asim Mohammad,Williams Kamery J.,Hawkins Caroline V.,Jacobse Justin,Goettel Jeremy A.,Delgado Alberto G.,Piazuelo M. Blanca,Washington M. Kay,Gobert Alain P.,Wilson Keith T.
Abstract
AbstractThe intestinal immune response is crucial in maintaining a healthy gut, but the enhanced migration of macrophages in response to pathogens is a major contributor to disease pathogenesis. Integrins are ubiquitously expressed cellular receptors that are highly involved in immune cell adhesion to endothelial cells while in the circulation and help facilitate extravasation into tissues. Here we show that specific deletion of the Tln1 gene encoding the protein talin-1, an integrin-activating scaffold protein, from cells of the myeloid lineage using the Lyz2-cre driver mouse reduces epithelial damage, attenuates colitis, downregulates the expression of macrophage markers, decreases the number of differentiated colonic mucosal macrophages, and diminishes the presence of CD68-positive cells in the colonic mucosa of mice infected with the enteric pathogen Citrobacter rodentium. Bone marrow-derived macrophages lacking expression of Tln1 did not exhibit a cell-autonomous phenotype; there was no impaired proinflammatory gene expression, nitric oxide production, phagocytic ability, or surface expression of CD11b, CD86, or major histocompatibility complex II in response to C. rodentium. Thus, we demonstrate that talin-1 plays a role in the manifestation of infectious colitis by increasing mucosal macrophages, with an effect that is independent of macrophage activation.
Funder
National Institutes of Health
Crohn's and Colitis Foundation of America
U.S. Department of Defense
Publisher
Springer Science and Business Media LLC